Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
topic_facet:"Antibodies, Monoclonal"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
PubPharm (403)
1
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis : 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Ritchlin, C.
|
Coates, L.
|
McInnes, I.
| +12
Wird geladen...
2
Efficacy and safety of emapalumab in macrophage activation syndrome
enthalten in:
Annals of the rheumatic diseases
| 2023
von
De Benedetti, F.
|
Grom, A.
|
Brogan, P.
| +14
CommentIn: Nat Rev Rheumatol. 2023 Jun;19(6):326. - PMID 37147459
Wird geladen...
3
Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Landon-Cardinal, O.
|
Allard-Chamard, H.
|
Chapdelaine, H.
| +3
Wird geladen...
4
Response to : 'Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'' by Satis et al
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Ozen, S.
|
De Benedetti, F.
CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1362-1369. - PMID 32571870
Wird geladen...
5
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy : efficacy and safety results of a randomised controlled phase III study
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Feist, E.
|
Fatenejad, S.
|
Grishin, S.
| +6
Wird geladen...
6
Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Kerschbaumer, A.
|
Rivai, Z.
|
Smolen, J.
| +1
Wird geladen...
7
Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate : efficacy and safety results of a randomised controlled phase III study
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Nasonov, E.
|
Fatenejad, S.
|
Feist, E.
| +8
Wird geladen...
8
Efficacy and safety of risankizumab for active psoriatic arthritis : 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Östör, A.
|
Van den Bosch, F.
|
Papp, K.
| +10
CommentIn: Nat Rev Rheumatol. 2022 Mar;18(3):127. - PMID 35082372
Wird geladen...
9
Efficacy and safety of risankizumab for active psoriatic arthritis : 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Kristensen, L.
|
Keiserman, M.
|
Papp, K.
| +8
CommentIn: Nat Rev Rheumatol. 2022 Mar;18(3):127. - PMID 35082372
Wird geladen...
10
Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis : 16-week results from a randomised, placebo-controlled, phase 3 trial
enthalten in:
Annals of the rheumatic diseases
| 2021
von
Wei, J.
|
Kim, T.
|
Kishimoto, M.
| +54
CommentIn: Ann Rheum Dis. 2023 Jul;82(7):e168. - PMID 34172501
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[41]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Thema: Antibodies, Monoclonal
Medienart
403
Aufsätze
403
E-Artikel
E-Ressourcen
Zeitschriftentitel
403
Annals of the rheumatic diseases
Thema
Antibodies, Monoclonal
311
Journal Article
302
Antirheumatic Agents
245
Research Support, Non-U.S. Gov't
174
Antibodies, Monoclonal, Humanized
173
B72HH48FLU
173
Infliximab
173
Tumor Necrosis Factor-alpha
132
Randomized Controlled Trial
108
Multicenter Study
97
Adalimumab
97
FYS6T7F842
93
Methotrexate
91
YL5FZ2Y5U1
82
Letter
79
Immunoglobulin G
76
Etanercept
76
OP401G7OJC
75
Receptors, Tumor Necrosis Factor
51
Anti-TNF
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
15
2020-
265
2010-2019
123
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
403
Englisch
Haven't found what you're looking for?
Wird geladen...